Publications by Licensor Sample Clauses

Publications by Licensor. Subject to Section 11.4 (Authorized Disclosures), Section 11.5 (SEC Filings and Other Disclosures), and this Section 11.6(b) (Publications by Licensor), Licensor may make Publications relating to Licensed Compound or Licensed Products solely in connection with the Licensor Clinical Trial upon the prior written consent of Novartis. Subject to Section 6.3 (Clinical Trial Disclosures), if Licensor wishes to make any such Publication, Licensor shall provide Novartis the opportunity to review and comment on any proposed Publication at least [***] prior to its intended submission for publication. Licensor shall consider in good faith any comments thereto provided by Novartis within [***] following its receipt of the proposed Publication and shall comply with Novartis’ requests received within such [***] period to remove any and all of Novartis’ Confidential Information from the proposed Publication. In addition, Licensor shall delay the proposed Publication’s submission for a period up to [***] (as requested by Novartis) in the event that Novartis reasonably requests such a delay, including for the purpose of preparing and filing a patent application. Licensor shall provide Novartis a copy of the Publication manuscript at the time of the submission. Licensor shall acknowledge the contributions of Novartis and its employees in all Publications as scientifically appropriate.